Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
Studies assessing patient-centred outcomes of novel rifampicin resistant tuberculosis (RR-TB) diagnostics are rare and mostly apply conventional methods which may not adequately address biases. Even though the Xpert MTB/RIF molecular assay was endorsed a decade ago for simultaneous diagnosis of tube...
Saved in:
Main Authors: | Elise De Vos (Author), Daniel Westreich (Author), Lesley Scott (Author), Yara Voss de Lima (Author), Wendy Stevens (Author), Cindy Hayes (Author), Pedro da Silva (Author), Annelies Van Rie (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Xpert MTB/RIF: a game changer for the diagnosis of pulmonary tuberculosis in children?
by: Annelies Van Rie
Published: (2013) -
Utilization of GeneXpert MTB/RIF Assay for Prevalence Mapping of Rifampicin Resistant Mycobacterium tuberculosis in A Teaching Hospital, Indonesia
by: P. Christopher, et al.
Published: (2020) -
Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017) -
False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients
by: Charlotte Schutz, et al.
Published: (2019) -
Utility of Xpert MTB/RIF Assay for Diagnosis of Pediatric Tuberculosis Under Programmatic Conditions in India
by: Rakesh Yadav, et al.
Published: (2020)